|
1.
|
Gheuens S, Cheeseman SH, Koralnik IJ. Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis. Acta Neurol Belg. 2011 Sep; 111(3):217-9.
|
|
|
|
|
2.
|
Mazzola JL, Belliveau PP, Cheeseman SH. Guidelines for liposomal amphotericin B. Am J Health Syst Pharm. 2003 Jul 15; 60(14):1480-1.
|
|
|
|
|
3.
|
Simsir SA, Cheeseman SH, Lancey RA, Vander Salm TJ, Gammie JS. Staged laparoscopic splenectomy and valve replacement in splenic abscess and infective endocarditis. Ann Thorac Surg. 2003 May; 75(5):1635-7.
|
|
|
|
|
4.
|
Alagiriswami A, Cheeseman SH. Influenza and HIV: case report and review of potential interactions. AIDS Patient Care STDS. 2001 Nov; 15(11):561-5.
|
|
|
|
|
5.
|
Radwan HM, Cheeseman SH, Lai KK, Ellison III RT. Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. Clin Infect Dis. 2000 Aug; 31(2):604-6.
|
|
|
|
|
6.
|
Sharkey ME, Teo I, Greenough T, Sharova N, Luzuriaga K, Sullivan JL, Bucy RP, Kostrikis LG, Haase A, Veryard C, Davaro RE, Cheeseman SH, Daly JS, Bova C, Ellison RT, Mady B, Lai KK, Moyle G, Nelson M, Gazzard B, Shaunak S, Stevenson M. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med. 2000 Jan; 6(1):76-81.
|
|
|
|
|
7.
|
Gerstadt K, Daly JS, Mitchell M, Wessolossky M, Cheeseman SH. Methicillin-resistant Staphylococcus intermedius pneumonia following coronary artery bypass grafting. Clin Infect Dis. 1999 Jul; 29(1):218-9.
|
|
|
|
|
8.
|
Havlir DV, Dubé MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Kumar PN, White AC, Witt MD, Nightingale SD, Sepkowitz KA, MacGregor RR, Cheeseman SH, Torriani FJ, Zelasky MT, Sattler FR, Bozzette SA. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clin Infect Dis. 1998 Dec; 27(6):1369-75.
|
|
|
|
|
9.
|
Neary B, Young SB, Reuter KL, Cheeseman S, Savarese D. Ovarian Burkitt lymphoma: pelvic pain in a woman with AIDS. Obstet Gynecol. 1996 Oct; 88(4 Pt 2):706-8.
|
|
|
|
|
10.
|
Davaro RE, Cheeseman SH, Keroack MA, Ellison RT. The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus. Clin Infect Dis. 1996 Jul; 23(1):189-90.
|
|
|
|
|
11.
|
Kessler HA, Hurwitz S, Farthing C, Benson CA, Feinberg J, Kuritzkes DR, Bailey TC, Safrin S, Steigbigel RT, Cheeseman SH, McKinley GF, Wettlaufer B, Owens S, Nevin T, Korvick JA. Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1; 12(2):147-52.
|
|
|
|
|
12.
|
Cheeseman SH, Davaro RE, Ellison RT. Hepatitis B vaccination and plasma HIV-1 RNA. N Engl J Med. 1996 May 9; 334(19):1272.
|
|
|
|
|
13.
|
Moore KH, Raasch RH, Brouwer KL, Opheim K, Cheeseman SH, Eyster E, Lemon SM, van der Horst CM. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062). Antimicrob Agents Chemother. 1995 Dec; 39(12):2732-7.
|
|
|
|
|
14.
|
Havlir D, Cheeseman SH, McLaughlin M, Murphy R, Erice A, Spector SA, Greenough TC, Sullivan JL, Hall D, Myers M, et al. High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis. 1995 Mar; 171(3):537-45.
|
|
|
|
|
15.
|
Meng TC, Fischl MA, Cheeseman SH, Spector SA, Resnick L, Boota A, Petrakis T, Wright B, Richman DD. Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Feb 1; 8(2):152-60.
|
|
|
|
|
16.
|
Cheeseman SH, Havlir D, McLaughlin MM, Greenough TC, Sullivan JL, Hall D, Hattox SE, Spector SA, Stein DS, Myers M, et al. Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Feb 1; 8(2):141-51.
|
|
|
|
|
17.
|
Snydman DR, Werner BG, Meissner HC, Cheeseman SH, Schwab J, Bednarek F, Kennedy JL, Herschel M, Magno A, Levin MJ, et al. Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates. Pediatr Infect Dis J. 1995 Jan; 14(1):34-40.
|
|
|
|
|
18.
|
Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D, et al. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J Virol. 1994 Mar; 68(3):1660-6.
|
|
|
|
|
19.
|
Cheeseman SH, Hattox SE, McLaughlin MM, Koup RA, Andrews C, Bova CA, Pav JW, Roy T, Sullivan JL, Keirns JJ. Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrob Agents Chemother. 1993 Feb; 37(2):178-82.
|
|
|
|
|
20.
|
Rose PG, Cheeseman SH. Advanced ovarian carcinoma managed in an HIV-positive patient. Gynecol Oncol. 1993 Jan; 48(1):132-4.
|
|
|
|
|
21.
|
Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH. Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch Intern Med. 1990 Jun; 150(6):1305-9.
|
|
|
|
|
22.
|
Carroll K, Cheeseman SH, Fink MP, Umali CB, Cohen IT. Secondary infection of post-traumatic pulmonary cavitary lesions in adolescents and young adults: role of computed tomography and operative debridement and drainage. J Trauma. 1989 Jan; 29(1):109-12.
|
|
|
|
|
23.
|
Cheeseman SH. Infectious mononucleosis. Semin Hematol. 1988 Jul; 25(3):261-8.
|
|
|
|
|
24.
|
Rothman AL, Cheeseman SH, Lehrman SN, Cederbaum A, Glew RH. Herpes simplex encephalitis in a patient with lymphoma. Relapse following acyclovir therapy. JAMA. 1988 Feb 19; 259(7):1056-7.
|
|
|
|
|
25.
|
Cheeseman SH, Pierik LT, Leombruno D, Spinos KE, McIntosh K. Evaluation of a commercially available direct immunofluorescent staining reagent for the detection of respiratory syncytial virus in respiratory secretions. J Clin Microbiol. 1986 Jul; 24(1):155-6.
|
|
|
|
|
26.
|
Sullivan JL, Brewster FE, Brettler DB, Forsberg AD, Cheeseman SH, Byron KS, Baker SM, Willitts DL, Lew RA, Levine PH. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr. 1986 Apr; 108(4):504-10.
|
|
|
|
|
27.
|
Kinney JS, Onorato IM, Stewart JA, Pass RF, Stagno S, Cheeseman SH, Chin J, Kumar ML, Yaeger AS, Herrmann KL, et al. Cytomegaloviral infection and disease. J Infect Dis. 1985 May; 151(5):772-4.
|
|
|
|
|
28.
|
Groopman JE, Salahuddin SZ, Sarngadharan MG, Mullins JI, Sullivan JL, Mulder C, O'Hara CJ, Cheeseman SH, Haverkos H, Forgacs P, et al. Virologic studies in a case of transfusion-associated AIDS. N Engl J Med. 1984 Nov 29; 311(22):1419-22.
|
|
|
|
|
29.
|
Aucoin PJ, Cheeseman SH. Late-onset group B streptococcal disease after peripartum ampicillin prophylaxis. Am J Dis Child. 1984 Aug; 138(8):795.
|
|
|
|
|
30.
|
Cheeseman SH, Sullivan JL, Brettler DB, Levine PH. Analysis of cytomegalovirus and Epstein-Barr virus antibody responses in treated hemophiliacs. Implications for the study of acquired immune deficiency syndrome. JAMA. 1984 Jul 6; 252(1):83-5.
|
|
|
|
|
31.
|
Cheeseman SH, Doern GV, Ferriani RA, Keville MW, McGraw BR, Stewart JA. Detection of cytomegalovirus antibody with two commercially available assays, an indirect hemagglutination test and an enzyme immunosorbent assay. J Clin Microbiol. 1984 Jul; 20(1):9-11.
|
|
|
|
|
32.
|
Cheeseman SH, McGraw BR. Studies on cytomegalovirus in human milk. J Infect Dis. 1983 Sep; 148(3):615-6.
|
|
|
|
|
33.
|
Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, Rubin RH. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 9; 305(2):57-63.
|
|
|
|
|
34.
|
Bell DM, Brink EW, Nitzkin JL, Hall CB, Wulff H, Berkowitz ID, Feorino PM, Holman RC, Huntley CL, Meade RH, Anderson LJ, Cheeseman SH, Fiumara NJ, Gilfillan RF, Keim DE, Modlin JF. Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med. 1981 Jun 25; 304(26):1568-75.
|
|
|
|
|
35.
|
Fischer RA, Doern GV, Cheeseman SH. Pseudomonas denitrificans meningitis. J Clin Microbiol. 1981 May; 13(5):1004-6.
|
|
|
|
|
36.
|
Cheeseman SH, Henle W, Rubin RH, Tolkoff-Rubin NE, Cosimi B, Cantell K, Winkle S, Herrin JT, Black PH, Russell PS, Hirsch MS. Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. Ann Intern Med. 1980 Jul; 93(1):39-42.
|
|
|
|
|
37.
|
Cheeseman SH, Black PH, Rubin RH, Cantell K, Hirsch MS. Interferon and BK Papovavirus--clinical and laboratory studies. J Infect Dis. 1980 Feb; 141(2):157-61.
|
|
|
|
|
38.
|
Cheeseman SH, Rubin RH, Stewart JA, Tolkoff-Rubin NE, Cosimi AB, Cantell K, Gilbert J, Winkle S, Herrin JT, Black PH, Russell PS, Hirsch MS. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med. 1979 Jun 14; 300(24):1345-9.
|
|
|
|
|
39.
|
Cheeseman SH, Stewart JA, Winkle S, Cosimi AB, Tolkoff-Rubin NE, Russell PS, Baker GP, Herrin J, Rubin RH. Cytomegalovirus excretion 2-14 years after renal transplantation. Transplant Proc. 1979 Mar; 11(1):71-4.
|
|
|
|
|
40.
|
Cheeseman SH, Hirsch MS, Keller EW, Keim DE. Fatal neonatal pneumonia caused by Echovirus type 9. Am J Dis Child. 1977 Oct; 131(10):1169.
|
|
|
|
|
41.
|
Cheeseman SH, Rinaldo CR, Hirsch MS. Use of interferon in cytomegalovirus infections in man. Tex Rep Biol Med. 1977; 35:523-7.
|
|
|
|
